SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-24-000098
Filing Date
2024-08-07
Accepted
2024-08-07 06:07:59
Documents
105
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20240630.htm   iXBRL 10-Q 2195997
2 EX-10.3 exhibit103-offerletterbyan.htm EX-10.3 49801
3 EX-10.4 exhibit104-juliawangsepara.htm EX-10.4 77032
4 EX-10.5 exhibit105-psuawardagreeme.htm EX-10.5 121440
5 EX-10.6 exhibit106-rsuawardagreeme.htm EX-10.6 209955
6 EX-10.7 exhibit107-rsuawardagreeme.htm EX-10.7 155292
7 EX-10.8 exhibit108-nqshareoptionag.htm EX-10.8 218861
8 EX-10.9 exhibit109-nqshareoptionag.htm EX-10.9 152105
9 EX-31.1 exhibit311-2024q2.htm EX-31.1 9956
10 EX-31.2 exhibit312-2024q2.htm EX-31.2 9949
11 EX-32.1 exhibit321-2024q2.htm EX-32.1 6346
17 bgne-20240630_g1.jpg GRAPHIC 16225
18 image_0.jpg GRAPHIC 8339
  Complete submission text file 0001651308-24-000098.txt   11176933

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20240630.xsd EX-101.SCH 69258
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20240630_cal.xml EX-101.CAL 89364
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20240630_def.xml EX-101.DEF 286981
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20240630_lab.xml EX-101.LAB 728019
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20240630_pre.xml EX-101.PRE 518924
108 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20240630_htm.xml XML 1570413
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 241181288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)